AzTrials
AzTrials

Esophageal AchalasiaNCT07686471

Short Versus Long Submucosal Tunneling in Per-oral Endoscopic Myotomy (POEM) for Type II Achalasia.

A study testing per-oral endoscopic myotomy in people with Esophageal Achalasia, run by Assiut University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

this study is prospective , randomized and interventional ,will be performed on 50 patients to compare the clinical utility , safety profile and postoperative recovery metrics between short and long per-oral endoscopic myotomy , patients will be divided randomly into two equal groups one will do short myotomy and the… Read more about this study

Who is it for?
Any age
Conditions the study is for
Esophageal Achalasia
What is being tested?
per-oral endoscopic myotomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
28 Jun 2026to 16 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients of all ages were eligible for inclusion in the study with no upper or lower age limits applied .
  • Both sexes are included .
  • Type II achalasia patients who are diagnosed by High Resolution. Manometry based on Chicago Classification (v4.0) characterized by (failed esophageal peristalsis , pan-esophageal pressurization in ≥20% of swallows and Integrated Relaxation Pressure (IRP) >15 mmHg ).
  • Eckardt score >3 ( moderate to severe symptoms

Who cannot join

  • Type I ,type III achalasia \& Non-achalasia spastic motility disorders.
  • Sigmoid type esophagus (diameter> 6 cm ).
  • Esophageal diverticulae .
  • Presence of large Hiatus Hernia ( >5cm).
  • Severe erosive esophagitis (La Grade C or D) or Barrett's Esophagus.
  • History of previous Heller's myotomy.
  • Pseudoachalasia due to underlying malignancy.
  • Severe coagulopathy ( INR>1.5 or platelets <50000 ).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

omar m magdy, Master dgree contact

+201062983336

omar.megooz96@gmail.com

Egypt1 site
  • Assiut university hosoital

    Asyut, 71511

    omar M magdy, Master degree, 01062983336, omar.megooz96@gmail.com

Other trials in Egypt

About this study

Official title: Short Versus Long Submucosal Tunneling in Per-oral Endoscopic Myotomy (POEM) for Type II Achalasia: A Randomized Controlled Trial

this study is prospective , randomized and interventional ,will be performed on 50 patients to compare the clinical utility , safety profile and postoperative recovery metrics between short and long per-oral endoscopic myotomy , patients will be divided randomly into two equal groups one will do short myotomy and the other group will do long myotomy , each group will contain 25 patients methodology \&patient selection : patients follow the inclusion criterias including :

  • Patients of all ages were eligible for inclusion in the study with no upper or lower age limits applied .
  • Both sexes are included .
  • Type II achalasia patients who are diagnosed by High Resolution. Manometry based on Chicago Classification (v4.0) characterized by (failed esophageal peristalsis , pan-esophageal pressurization in ≥20% of swallows and Integrated Relaxation Pressure (IRP) >15 mmHg ).
  • Eckardt score >3 ( moderate to severe symptoms). this study aims to compare the outcomes of short versus long esophageal myotomy in cases with type II achalasia using Eckardt score and barium study at 3 month follow up. also to evaluate difference in length of the opearation , intra-operative and post-operative adverse events between short and long submucosal tunneling. every patient will do upper endoscopy and manometry preoperative , also ekcardt score will be caculated , follow up after 3 months by barium swallow and eckardt score
Read the detailed description

Aim of the study :

Primary outcome :

to compare the outcomes of short versus long esophageal myotomy in cases with type II achalasia using Eckardt score and barium study at 3 month follow up.

to evaluate difference in length of the opearation , intra-operative and post-operative adverse events between short and long submucosal tunneling.

Secondary outcome :

We aim to compare the difference in duration of hospital stay between short and long esophageal myotomy .

We aim to compare the incidence of post-operative Gastroesophageal Reflux Disease (GERD) using Los Angeles (LA) classification via upper endoscopy at 3 months.

Patients and Methods Study Design: prospective , randomized . Patients:this study will include all patients diagnosed as type II achalasia via High Resolution Manometry , this study will be conducted in internal medicine department at Assiut University Hospitals between june 2026 to june 2028.

Inclusion criteria:

Patients of all ages were eligible for inclusion in the study with no upper or lower age limits applied .

Both sexes are included . Type II achalasia patients who are diagnosed by High Resolution. Manometry based on Chicago Classification (v4.0) characterized by (failed esophageal peristalsis , pan-esophageal pressurization in ≥20% of swallows and Integrated Relaxation Pressure (IRP) >15 mmHg ).

Eckardt score >3 ( moderate to severe symptoms).

Exclusion criteria :

Type I ,type III achalasia \& Non-achalasia spastic motility disorders. Sigmoid type esophagus (diameter> 6 cm ). Esophageal diverticulae . Presence of large Hiatus Hernia ( >5cm). Severe erosive esophagitis (La Grade C or D) or Barrett's Esophagus. History of previous Heller's myotomy. Pseudoachalasia due to underlying malignancy. Severe coagulopathy ( INR>1.5 or platelets <50000 ).

Methodology :

All patients will be subjected to the following:

Preoperative evaluation:

•Eckardt score: All patients were assessed using the Eckardt score for symptom severity, which is based on dysphagia, chest pain, regurgitation, and weight loss symptoms. Each component of the Eckardt score is assigned a value from 0 to 3 according to the patient's self-reported response, with the total score ranging from 0 to 12. Higher scores indicate more severe symptoms.(7)

Upper Gastrointestinal Endoscopy :

Patients shoud be fasting for 8 hours and the procedure was performed under general anesthesia It is used to comment on esophageal peristalsis, dilatation, LES, any residual food were noted.

High Resolution Manometry :

All the patients assessed by High Resolution Manometry , for evaluation of esophageal peristalsis, LES pressure, integral resting pressure (IRP), and ineffective contractions and to differentiate between achalasia types.

Certain instructions were followed :

Patients were instructed to stop any medication that may influence esophageal motility (calcium channel blocker, nitrates, loperamide, prokinetics, beta-blocker, and opioids).

Patients were instructed for complete fasting for 12h before procedure. An HRM catheter was introduced transnasally in the supine position and positioned by observing the appearance of a high-pressure zone at the distal end of the LES.

Patients were instructed not to swallow for 30 s to detect the resting pressure among esophagus.

Patients were then instructed to take 5ml of water in each swallow of 10 successive swallows separated by 30 s interval for assessment of esophageal body peristalsis.(8)

Barium swallow :

it is performed to all patients to detect bird peak appearance , dilated esophagus ,retained food or sigmoid esophagus.

Hematological investigation :

Venous blood samples will be drawn into 2 mL EDTA tubes. Complete blood count will be analyzed within 2 hours after venipuncture using an automated hematology analyzer. The parameters analyzed will be Hemoglobin, platelet count and White Blood Cells.

Differential leucocyte counts will be done on peripheral smear. Neutrophil -to-Lymphocyte Ratio (NLR) will be calculated.

Other hematological parameters will be done like (CRP and ESR ). Coagulation profile (PC , PT ,INR )

Per-oral Endoscopic Myotomy Technique :

POEM was performed by experienced endoscopist . All procedures were performed under general anesthesia with the patients in the supine position. POEM was performed by anterior (1-2 O'clock) route in all cases. The steps of POEM procedure were as follows:

submucosal injection using a solution of saline mixed with indigocarmine dye . vertical mucosal incision measuring 2 cm to 2.5 cm in length. submucosal tunneling extending up to 2 cm to 4 cm below the Gastroesophageal junction ( GEJ) .

myotomy extending from 1 cm to 2 cm below the distal edge of mucosal incision until the lower end of the tunnel and closure of the mucosal incision with several endoclips ,Triangular tip knife (KD-645L; Olympus, Tokyo, Japan) with integrated water jet function was utilized for the entire procedure including mucosal incision, submucosal tunneling, and myotomy (Spray Coag 50 W).

The important technical differences in the short and long myotomy groups were as follows. The length of esophageal myotomies (≤ 3 cm vs ≥ 6 cm) were different in both groups. Whereas, the length of gastric myotomies were similar (2-4 cm) in either group. In the short myotomy group, the mucosal incision was performed at about 5-6 cm above the gastroesophageal junction (GEJ). The length of esophageal myotomy was 2 cm to 3 cm and the entire extent of the myotomy was full thickness in the short myotomy group. Whereas in the long myotomy group, the mucosal incision was performed at least 8 cm above the GEJ and the length of esophageal myotomy was ≥ 6 cm. Selective circular myotomy was performed in the upper part of the tunnel and full thickness myotomy was performed from 2-3 cm above the GEJ until the lower end of the tunnel. The length of gastric myotomy was kept similar in both groups ie, 2-4 cm. The extent of esophageal and gastric myotomies were assessed using scope withdrawal, and fluoroscopy . In cases with uncertainty regarding the gastric length of myotomy, double scope method was used for confirmation.(9) Adverse events: events requiring an additional procedure such as needle drainage for capno-peritoneum, temporary cessation of procedure due to accumulation of retroperitoneal CO2 , mucosal injuries requiring closure with endoclips, and intra-procedural or post-procedural events leading to prolongation of hospital stay were considered as adverse events.(10)

Postoperative evaluation :

All patients will be followed up by hematological investigations like CBC , CRP and ESR to all patients 24 hrs postoperative.

All patients will be followed up by barium swallow and Eckardt score at 3 month duration .

All patients will be underwent upper endoscopy at 3 months duration .

Being tested
per-oral endoscopic myotomy
Keywords
achalasia type II
Medical subject headings
Esophageal Achalasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • per-oral endoscopic myotomyProcedure or surgery

    Per-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a submucosal tunnel extending down to the esophagogastric junction; (3) endoscopic myotomy of the circular muscle layer, where the longitudinal length of the myotomy (short vs. long) is determined strictly by the patient's randomized group assignment; and (4) closure of the mucosal entry site using endoscopic clips.

Study groups in NCT07686471
Study groupRoleWhat they receive
short POEM groupExperimentalPer-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a short submucosal tunnel extending down to the esophagogastric junction; (3) short endoscopic myotomy of the circular muscle layer; and (4) closure of the mucosal entry site using endoscopic clips
Receives: Procedure: per-oral endoscopic myotomy
long POEM groupExperimentalPer-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a long submucosal tunnel extending down to the esophagogastric junction; (3) long endoscopic myotomy of the circular muscle layer; and (4) closure of the mucosal entry site using endoscopic clips.
Receives: Procedure: per-oral endoscopic myotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change from baseline eckardt score at 3 months

    the eckardt score is a clinical grading for achalasia evaluating four symtoms dysphagia , regurgitation , retrosternal pain and weight loss ( each scored 0to3 , total score ranges from 0 to 12 where higher scores indicate severe symtoms

    Measured: 3 months postoperatively

  2. postoperative barium column height at 3 months

    evaluation of esophageal emptying by measuring the height of timed barium in centimeters at 1,2and 5 minutes during the barium swallow

    Measured: 3 month postoperatively

  3. total operative operation

    total time taken to complete the procedure , measured in minutes from initial mucosal incision to final closure

    Measured: during the operation (from incision to closure )

  4. incidence of intraoperative adverse events

    number of participants who experience intraoperative complications such as mucosal perforation or significant hemorrhage during submucosal tunneling

    Measured: during the operation

  5. post-operative complications

    number of participants experiencing post-operative complications ( e.g delayed bleeding , infection,or leakage )

    Measured: from the completion of operation upto the hospital discharge ( within 48 hr)

Secondary outcomes (2)
  1. length of hospital stay

    total number of days spent in the hospital , calculatef from day of the procedure until the day of official hospital discharge

    Measured: from day of the procedure until the day of official hospital discharge

  2. incidence of post-operative reflux esophagitis

    the percentage of participants diagnosed with gastresophageal reflux disease ( GERD)evaluated via upper gastrointestinal endoscopy and graded according to los angelos(LA) classification system (grades A to D , where higher grades indicate more severe mucosal breaks

    Measured: 3 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2026
  2. Study start28 Jun 2026 (estimated)
  3. Primary completion16 Jun 2028 (estimated)
  4. Study completion16 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07686471
Sponsor's protocol ID
04-2026-100498
Status last verified
Jun 2026
First submitted
24 Jun 2026
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing per-oral endoscopic myotomy in people with Esophageal Achalasia, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact omar m magdy, Master dgree (+201062983336, omar.megooz96@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change from baseline eckardt score at 3 months (time frame: 3 months postoperatively). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in